Effect of the p38 kinase inhibitor, SB203580, in a model of airway inflammation

被引：0
|
作者：
Birrell, M [1 ]
Haddad, EB [1 ]
McCluskie, K [1 ]
Hele, D [1 ]
Phipps, S [1 ]
Webber, SE [1 ]
Foster, M [1 ]
Belvisi, MG [1 ]
机构：
[1] Rhone Poulenc Rorer Res & Dev, Dagenham Res Ctr, Dept Pharmacol, Dagenham RM10 7XS, Essex, England
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 1998年 / 125卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
89P
引用
收藏
页码：U46 / U46
页数：1
相关论文
共 50 条
  • [41] A p38 MAP kinase inhibitor SB203580 inhibits CD28-dependent T cell proliferation and IL-2 production.
    Ward, SG
    Parry, RV
    Matthews, J
    ONeill, L
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1997, 25 (02) : S304 - S304
  • [42] The p38 mitogen-activated protein kinase inhibitor SB203580 can antagonise P2X7 receptor-mediated responses.
    Michel, D
    Thompson, KM
    Humphrey, PPA
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 133 : U112 - U112
  • [43] Preclinical pharmacokinetics of SB-203580, a potent inhibitor of p38 mitogen-activated protein kinase
    Ward, KW
    Proksch, JW
    Azzarano, LM
    Mumaw, JA
    Roethke, TJ
    Stelman, GJ
    Walsh, MJ
    Zeigler, KS
    McSurdy-Freed, JE
    Kehler, JR
    Chokshi, J
    Levy, MA
    Smith, BR
    XENOBIOTICA, 2001, 31 (11) : 783 - 797
  • [44] Administration of the p38 MAPK inhibitor SB203580 affords brain protection with a wide therapeutic window against focal ischemic insult
    Piao, CS
    Kim, JB
    Han, PL
    Lee, JK
    JOURNAL OF NEUROSCIENCE RESEARCH, 2003, 73 (04) : 537 - 544
  • [45] The p38 MAPK inhibitor SB203580 blocks adenosine A1 receptor-induced attenuation of in vivo myocardial stunning
    Yoshimura, Y
    Kristo, G
    Keith, BJ
    Jahania, SA
    Mentzer, RM
    Lasley, RD
    CARDIOVASCULAR DRUGS AND THERAPY, 2004, 18 (06) : 433 - 440
  • [46] The immunophilin ligand FK506, but not the p38 kinase inhibitor SB203580, improves function of adult rat muscle reinnervated from transplants of embryonic neurons
    Grumbles, RM
    Casella, GTB
    Rudinsky, MJ
    Godfrey, S
    Wood, PM
    Thomas, CK
    NEUROSCIENCE, 2005, 130 (03) : 619 - 630
  • [47] SB203580, a p38 Inhibitor, Improved Cardiac Function but Worsened Lung Injury and Survival During Escherichia coli Pneumonia in Mice
    Su, Junwu
    Cui, Xizhong
    Li, Yan
    Mani, Haresh
    Ferreyra, Gabriela A.
    Danner, Robert L.
    Hsu, Lewis L.
    Fitz, Yvonne
    Eichacker, Peter Q.
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2010, 68 (06): : 1317 - 1327
  • [48] The p38 MAPK Inhibitor SB203580 Blocks Adenosine A1 Receptor-Induced Attenuation of In Vivo Myocardial Stunning
    Yukihiro Yoshimura
    Gentian Kristo
    Byron J. Keith
    Salik A. Jahania
    Robert M. Mentzer
    Robert D. Lasley
    Cardiovascular Drugs and Therapy, 2004, 18 : 433 - 440
  • [49] Induction of autophagy in hepatocellular carcinoma cells by SB203580 requires activation of AMPK and DAPK but not p38 MAPK
    Haitao Zhang
    George G. Chen
    Zhiyi Zhang
    Sukying Chun
    Billy Cheuk Sing Leung
    Paul B. S. Lai
    Apoptosis, 2012, 17 : 325 - 334
  • [50] Inhibition of p38 mitogen-activated protein kinase-induced apoptosis in cultured mature oligodendrocytes using SB2021.90 and SB203580
    Hamanoue, Makoto
    Sato, Kenichiro
    Takamatsu, Ken
    NEUROCHEMISTRY INTERNATIONAL, 2007, 51 (01) : 16 - 24
12345